Aimei Health risks Nasdaq delisting after market value falls below $50 million threshold

Aimei Health Technology received Nasdaq notices for failing Global Market market-value thresholds, raising the risk of a delisting process.

• Market value of listed securities stayed below USD 50 million for 30 straight business days, breaching Nasdaq Rule 5450(b)(2)(A).
• Market value of publicly held shares also fell below USD 15 million for 30 straight business days, breaching Nasdaq Rule 5450(b)(2)(C).
• Shares continue trading under AFJK, with 180 days to regain compliance by Feb. 17, 2027.
• Failure to cure could trigger a delisting notice, or a potential transfer application to the Nasdaq Capital Market.